After two years in the making, on Nov. 30, the US House passed the 21st Century Cure Act, which is now on the fast track to becoming law before the end of the Obama administration. (Also see "Senate Poised To Vote On Cures Bill; Headed To Likely Enactment This Term" - Medtech Insight, 1 December, 2016.) The bill includes a grab bag of reforms intended to streamline FDA processes for medical devices, funding for precision medicine, neurotechnology and cancer research and development and some Medicare reforms.
The table below highlights the provisions of most importance to the medtech space.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?